4//SEC Filing
Garland Jonathan Todd 4
Accession 0001209191-22-025897
CIK 0001831915other
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 8:07 PM ET
Size
8.2 KB
Accession
0001209191-22-025897
Insider Transaction Report
Form 4
Garland Jonathan Todd
Chief Commercial Officer
Transactions
- Award
Restricted Stock Units
2022-04-25+31,217→ 31,217 total→ Common Stock (31,217 underlying) - Award
Stock Option (right to buy)
2022-04-25+46,971→ 46,971 totalExercise: $9.61Exp: 2032-04-25→ Common Stock (46,971 underlying)
Footnotes (3)
- [F1]The option will vest as follows: 25% of the total shares underlying the option shall vest on April 25, 2023 and 1/48 of the total shares underlying the option shall vest each month thereafter.
- [F2]Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The shares subject to the RSU Award shall vest quarterly over four years, with 12/48th of the total shares underlying the RSU Award vesting on May 18, 2023 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18.
Documents
Issuer
Cytek Biosciences, Inc.
CIK 0001831915
Entity typeother
Related Parties
1- filerCIK 0001924824
Filing Metadata
- Form type
- 4
- Filed
- Apr 26, 8:00 PM ET
- Accepted
- Apr 27, 8:07 PM ET
- Size
- 8.2 KB